News

The RUHRC was established in 2016, with an initial HRSA funding award of $2.8 million. Since then, the Center has produced 22 research products, including policy briefs and peer-reviewed publications, as well as more than a dozen related publications.

Building on these findings, Plattner and Markey oncologists are now collaborating with the pharmaceutical company Novartis to develop a Phase I clinical trial to test the safety and effectiveness of using nilotinib in relapsed melanoma patients.

Although small tattoos are less likely to interfere with overall body temperature regulation, decreased sweating in tattooed skin “could impact heat dissipation especially when tattooing covers a higher percentage of body surface area,” the researchers wrote.

A $2.9 million grant from the NIH is supporting a multidisciplinary team of UK researchers in continuing their work to find therapeutic strategies to resolve neurovascular inflammation and repair blood-brain barrier dysfunction in epilepsy.

Dr. Emma Birks, UK HealthCare's heart failure section chief, is working on a new treatment therapy that recovers the hearts of some patients with advanced-stage chronic heart failure and ultimately cut down the number of heart transplants needed.

To curb overdose deaths, ease the financial burden on health care, and improve patient outcomes, the researchers worked with patients who need tools for recovery from opioid use disorder, such as mental health therapists, relapse-prevention services, and necessary medications.  

In the sessions for both the scientific and community audience, attendees will have the opportunity to hear clinicians and researchers from UK and other institutions share current findings, trends, and latest updates on dementia and aging disorders.

Kelly G. Pennell, Gill Associate Professor in the Department of Civil Engineering and director of the UK Superfund Research Center (UK-SRC), has co-authored an article detailing lessons learned about stakeholder engagement and risk communication relevant for COVID-19 and school reopening.

CAER is building an educational pilot plant to process collected electronic scrap. The plant will be designed, constructed & operated by students & will be financially supported by the sale of marketable metals.

"We need stronger and more united NMR capabilities at UK and securing funding for this new state-of-the-art NMR instrument is a first step toward achieving this important goal," Garneau-Tsodikova said.